HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Bischofberger Selected Research

Neutralizing Antibodies

11/2001Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Bischofberger Research Topics

Disease

11Infections
11/2001 - 02/2000
7Viremia
08/2003 - 02/2000
3Acquired Immunodeficiency Syndrome (AIDS)
11/2001 - 02/2000
2Virus Diseases (Viral Diseases)
08/2000 - 02/2000
1HIV Infections (HIV Infection)
08/2000
1Persistent Infection
03/2000

Drug/Important Bio-Agent (IBA)

7Tenofovir (Viread)FDA Link
08/2003 - 02/2000
3Pharmaceutical PreparationsIBA
11/2001 - 02/2000
3AdenineFDA LinkGeneric
08/2001 - 03/2000
3Reverse Transcriptase InhibitorsIBA
08/2001 - 08/2000
2Antiviral Agents (Antivirals)IBA
07/2000 - 02/2000
1RNA (Ribonucleic Acid)IBA
08/2003
1VaccinesIBA
11/2001
1Neutralizing AntibodiesIBA
11/2001
1Monoclonal AntibodiesIBA
11/2001
1Explosive Agents (Explosives)IBA
01/2001
1Viral RNAIBA
11/2000
1NucleosidesIBA
08/2000
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
07/2000
1ChemokinesIBA
07/2000

Therapy/Procedure

2Therapeutics
01/2001 - 02/2000
2Withholding Treatment
01/2001 - 03/2000
1Highly Active Antiretroviral Therapy (HAART)
01/2001
1Art Therapy
10/2000
1Chemoprevention
08/2000
1Drug Therapy (Chemotherapy)
02/2000